Masimo to Report First Quarter 2019 Financial Results after Market Close on Monday, May 6
April 22 2019 - 9:00AM
Business Wire
Conference call and webcast to begin at 1:30
p.m. PT (4:30 p.m. ET)
Masimo (NASDAQ: MASI) announced today that it will release first
quarter 2019 financial results for the period ended March 30, 2019,
after the market closes on Monday, May 6, 2019. The conference call
to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and
will be hosted by Joe Kiani, Chairman and Chief Executive Officer,
and Micah Young, Executive Vice President and Chief Financial
Officer.
A live webcast of the conference call will be available online
from the investor relations page of the company's corporate website
at www.masimo.com. The dial-in numbers are (888) 520-7182 for
domestic callers and +1 (706) 758-3929 for international callers.
The reservation code for both dial-in numbers is 2399557. After the
live webcast, the call will be available on Masimo's website
through June 6, 2019. In addition, a telephonic replay of the call
will be available through May 13, 2019. The replay dial-in numbers
are (855) 859-2056 for domestic callers and +1 (404) 537-3406 for
international callers. Please use reservation code 2399557.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative
noninvasive monitoring technologies. Our mission is to improve
patient outcomes and reduce the cost of care. In 1995, the company
debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse
oximetry, which has been shown in multiple studies to significantly
reduce false alarms and accurately monitor for true alarms. In
2005, Masimo introduced rainbow® Pulse CO-Oximetry technology,
allowing noninvasive and continuous monitoring of blood
constituents that previously could only be measured invasively,
including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth
Variability Index (PVi®), and more recently, Oxygen Reserve Index
(ORi™), in addition to SpO2, pulse rate, and perfusion index (Pi).
In 2014, Masimo introduced Root®, an intuitive patient monitoring
and connectivity platform with the Masimo Open Connect™ (MOC-9™)
interface, enabling other companies to augment Root with new
features and measurement capabilities. Masimo is also taking an
active leadership role in mHealth with products such as the
Radius-7™ wearable patient monitor, iSpO2® pulse oximeter for
smartphones, and the MightySat™ fingertip pulse oximeter.
Additional information about Masimo and its products may be found
at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient
Outcome and Reducing Cost of Care by Taking Noninvasive Monitoring
to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet,
PVI are trademarks or registered trademarks of Masimo.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190422005061/en/
Investor Contact:Eli Kammerman(949)
297-7077ekammerman@masimo.com
Media Contact:Irene Paigah(858)
859-7001irenep@masimo.com
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Apr 2023 to Apr 2024